Login

Categories

Careers Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:10:00
Where the world is headed versus where it currently exists|Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
WCI adds value by uncovering both long and short opportunities through in-depth original research|Mr. Obus, Partner,Wynnefield Capital Inc.
00:10:00
Enabling entrepreneurs across emerging markets since 1994|Mukul Gulati, President, Zephyr Management, LP
00:10:00
Navigating the Intersection of Politics and Medicine: Insights from a Health Ministry Veteran | Mr. Chi-Hsien Chan, CEO, Adimmune Corp .
00:10:00
Advancing Gene Therapy for Ocular Diseases: Lunar Phase 2 Trial Design and Clinical Significance | Laurent Fischer, CEO, Adverum Biotechnologies Inc .
00:10:00
Addex Therapeutics' Advancements in Allosteric Modulation and Collaborative Ventures in CNS Pharmaceuticals |Tim DyerCo , CEO, Addex Therapeutics Ltd.
00:10:00
Economist David Gladstone Forecasts Prolonged Elevated Produce Prices Pending Further Economic Opening|David J. Gladstone, Chairman & CEO,Gladstone Commercial Corporation
00:10:00
Exploring Entrepreneurial Journeys and Industry Insights| Gilles Avenard , CEO, Acticor Biotech SA.
00:10:00
Exploring the Landscape of Biotech Innovations| Gilles Avenard , CEO, Acticor Biotech SA.
00:10:00
Cutting-Edge Cancer Therapies and Financial Strategies at the Biotech Showcase in San Francisco| Sadesh Seth , CEO, Actinium Pharmaceuticals Inc.
00:10:00
In-depth discussion on neuro therapeutics and strategic priorities for the next 18 months by Actinogen Medical Ltd CEO|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
Developing Novel Therapy for Neurological Diseases Associated with Dysregulated Brain Cortisol|Steven Gourlay , CEO, Actinogen Medical Ltd.
00:10:00
Biotech CEO presents promising clinical trial results and upcoming milestones |Helen Tuvesson , CEO, Active Biotech AB
00:10:00
Biopharmaceutical CEO discusses promising Phase 3 trial results of a novel antibiotic for Clostridioides difficile Infections with potential market impact exceeding $1B |David P Luci , CEO, Acurx Pharmaceuticals Inc.
00:10:00
Exploring Biotech Advancements and Talent Growth in Washington |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
Pioneering Immune Medicine and Driving Collaborative Health Tech Solutions. |Chad Robbin , CEO, Adaptive Biotechnologies.
00:10:00
PE firms are more often reaching the investment term limits of their mandates|Shad F. Azimi, Managing Partner,Vanterra Capital Ltd.
00:10:00
Create value by strategically transforming the companies we acquire|Ramzi Musallam,CEO,Veritas Capital
00:10:00
Committed to making the world a better place.|Hans Vestberg,Chairman,Verizon Asset Management Corp.
00:10:00
Listen, strategize, and support our partners as we pursue our shared goals.|Jeffrey Ansell, Strategic Executive Advisor,Vestar Capital Partners

© 2017 - Townhall + Tv